These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7357185)

  • 1. Modulation of nuclear oestrogen receptor levels by oestrogen and antioestrogen [proceedings].
    Dix CJ; Jordan VC
    Br J Pharmacol; 1980 Jan; 68(1):170P-171P. PubMed ID: 7357185
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells.
    Eckert RL; Katzenellenbogen BS
    Cancer Res; 1982 Jan; 42(1):139-44. PubMed ID: 7053842
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiestrogen modulation of the salt-resistant nuclear estrogen receptor.
    Ruh TS; Baudendistel LJ
    Endocrinology; 1978 Jun; 102(6):1838-46. PubMed ID: 744052
    [No Abstract]   [Full Text] [Related]  

  • 4. The stability of the uterine estrogen receptor when complexed with estrogens or antiestrogens.
    Pavlik EJ; Katzenellenbogen BS
    Mol Pharmacol; 1980 Nov; 18(3):406-12. PubMed ID: 7464805
    [No Abstract]   [Full Text] [Related]  

  • 5. Transcriptional activation of the oxytocin promoter by oestrogens uses a novel non-classical mechanism of oestrogen receptor action.
    Koohi MK; Ivell R; Walther N
    J Neuroendocrinol; 2005 Apr; 17(4):197-207. PubMed ID: 15842231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of antioestrogens on the oestrogen receptor.
    Ruh TS; Baudendistel LJ; Nicholson WF; Ruh MF
    J Steroid Biochem; 1979 Jul; 11(1A):315-22. PubMed ID: 491601
    [No Abstract]   [Full Text] [Related]  

  • 7. Genomic cross-talk between the estrogen receptor and growth factor regulatory pathways in estrogen target tissues.
    Chalbos D; Philips A; Rochefort H
    Semin Cancer Biol; 1994 Oct; 5(5):361-8. PubMed ID: 7849264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestrogen and anti-oestrogen induction of specific gene expression in human breast cancer cells.
    Chan CM; Green CD
    Biochem Soc Trans; 1990 Aug; 18(4):566-7. PubMed ID: 2276440
    [No Abstract]   [Full Text] [Related]  

  • 9. [The pharmacology of estrogens].
    Mohr K
    Pharm Unserer Zeit; 2004; 33(5):360-4. PubMed ID: 15497330
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of oestrogen receptor activity by oestrogens and anti-oestrogens.
    Green S
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):747-51. PubMed ID: 2285586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The molecular mechanisms of estrogens. Clinical aspects, industrial estrogens and phytoestrogens].
    Hagen ML; Hellmers M; Abrahamsen B; Hagen C
    Ugeskr Laeger; 2004 Mar; 166(13):1220-4. PubMed ID: 15088482
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of three week tamoxifen treatment on oestrogen receptor levels in primary breast tumours: a flow cytometric study.
    Sheard M
    Br J Cancer; 1999 Mar; 79(9-10):1621. PubMed ID: 10188917
    [No Abstract]   [Full Text] [Related]  

  • 13. Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E.
    Butt AJ; McNeil CM; Musgrove EA; Sutherland RL
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S47-59. PubMed ID: 16113099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of estrogen tumorigenesis in the Syrian golden hamster kidney by antiestrogens.
    Li JJ; Cuthbertson TL; Li SA
    J Natl Cancer Inst; 1980 Apr; 64(4):795-800. PubMed ID: 6928993
    [No Abstract]   [Full Text] [Related]  

  • 15. The oestrogen receptor in the rat hypothalamus: nuclear responses to oestrogen administration [proceedings].
    White JO; Lim L
    Biochem Soc Trans; 1978; 6(6):1310-2. PubMed ID: 744414
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of estrogen action during preimplantation period and in immature estradiol-primed rat uterus by anti-implantation agent, ormeloxifene.
    Dwivedi A; Basu R; Chowdhury SR; Goyal N
    Contraception; 2005 Jun; 71(6):458-64. PubMed ID: 15914137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of oestrogen antagonism by nonsteroidal antioestrogens.
    Sutherland RL; Murphy LC
    Mol Cell Endocrinol; 1982 Jan; 25(1):5-23. PubMed ID: 7040137
    [No Abstract]   [Full Text] [Related]  

  • 18. Heart estrogen receptor alpha: distinct membrane and nuclear distribution patterns and regulation by estrogen.
    Ropero AB; Eghbali M; Minosyan TY; Tang G; Toro L; Stefani E
    J Mol Cell Cardiol; 2006 Sep; 41(3):496-510. PubMed ID: 16876190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo modulation of murine serum tumour necrosis factor and interleukin-6 levels during endotoxemia by oestrogen agonists and antagonists.
    Zuckerman SH; Bryan-Poole N; Evans GF; Short L; Glasebrook AL
    Immunology; 1995 Sep; 86(1):18-24. PubMed ID: 7590877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of mifepristone on steroid receptor expression and biotransformation of oestrogen and progesterone in rat uterus and deciduoma.
    Vij U; Kumar A; Sharma K; Kaushal M; Mehra R
    Natl Med J India; 2006; 19(2):64-9. PubMed ID: 16756191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.